Indications and Purposes
| 1 Indications And Usage Jardiance Is Indicated: As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus, To Reduce The Risk Of Cardiovascular Death In Adult Patients With Type 2 Diabetes Mellitus And Established Cardiovascular Disease. Limitations Of Use Jardiance Is Not Recommended For Patients With Type 1 Diabetes Or For The Treatment Of Diabetic Ketoacidosis. Jardiance Is A Sodium-Glucose Co-Transporter 2 (Sglt2) Inhibitor Indicated: As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus, To Reduce The Risk Of Cardiovascular Death In Adult Patients With Type 2 Diabetes Mellitus And Established Cardiovascular Disease. ( 1 ) Limitations Of Use: Not For The Treatment Of Type 1 Diabetes Mellitus Or Diabetic Ketoacidosis ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Empagliflozin |
|
ZINC36520252 |